Documentation Centre

 

 

  of 1597 Next page

Go to page: of

Screenshot Date Categories Title Author Format
HDL cholesterol and ASCVD risk stratification: A debate. Atherosclerosis. 2019;283:7-12 July 03, 2019 HDL cholesterol and ASCVD risk stratification: A debate. Atherosclerosis. 2019;283:7-12 Barter P, Genest J Key Publications
Unaccounted risk of cardiovascular disease: the role of the microbiome in lipid metabolism. Curr Opin Lipidol. 2019;30:125-133 June 27, 2019 Unaccounted risk of cardiovascular disease: the role of the microbiome in lipid metabolism. Curr Opin Lipidol. 2019;30:125-133 Joris BR, Gloor GB Key Publications
From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants. Curr Opin Lipidol. 2019;30:101-107 June 26, 2019 From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants. Curr Opin Lipidol. 2019;30:101-107 Rhainds D, Tardif JC Key Publications
Diets enriched with conventional or high-oleic acid canola oils lower atherogenic lipids and lipoproteins compared to a diet with a western fatty acid profile in adults with central adiposity. J Nutr. 2019;149:471-478 June 26, 2019 Diets enriched with conventional or high-oleic acid canola oils lower atherogenic lipids and lipoproteins compared to a diet with a western fatty acid profile in adults with central adiposity. J Nutr. 2019;149:471-478 Bowen KJ, Kris-Etherton PM, West SG, Fleming JA, Connelly PW, Lamarche B, Couture P, Jenkins DJA, Taylor CG, Zahradka P, Hammad SS, Sihag J, Chen X, Guay V, Maltais-Giguère J, Perera D, Wilson A, Juan SCS, Rempel J, Jones PJH Key Publications
Meals with similar fat content from different dairy products induce different postprandial triglyceride responses in healthy adults: A randomized controlled cross-over trial. J Nutr. 2019;149:422-431 June 25, 2019 Meals with similar fat content from different dairy products induce different postprandial triglyceride responses in healthy adults: A randomized controlled cross-over trial. J Nutr. 2019;149:422-431 Hansson P, Holven KB, Øyri LKL, Brekke HK, Biong AS, Gjevestad GO, Raza GS, Herzig KH, Thoresen M, Ulven SM Key Publications
Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans. Eur J Clin Nutr. 2019;73(3):487-490 June 25, 2019 Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans. Eur J Clin Nutr. 2019;73(3):487-490 Kuzma JN, Cromer G, Hagman DK, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Weigle DS, Kratz M Key Publications
Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2019;282:52-56 June 21, 2019 Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2019;282:52-56 Saeed A, Sun W, Agarwala A, Virani SS, Nambi V, Coresh J, Selvin E, Boerwinkle E, Jones PH, Ballantyne CM, Hoogeveen RC Key Publications
LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study. Atherosclerosis. 2019;282:37-44 June 20, 2019 LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study. Atherosclerosis. 2019;282:37-44 Silbernagel G, Scharnagl H, Kleber ME, Delgado G, Stojakovic T, Laaksonen R, Erdmann J, Rankinen T, Bouchard C, Landmesser U, Schunkert H, März W, Grammer TB Key Publications
ApoB in clinical care: Pro and Con. Atherosclerosis. 2019;282:169-175 June 20, 2019 ApoB in clinical care: Pro and Con. Atherosclerosis. 2019;282:169-175 Sniderman AD, Robinson JG Key Publications
High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes. Atherosclerosis. 2019;282:183-187 June 20, 2019 High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes. Atherosclerosis. 2019;282:183-187 Heier M, Ofstad AP, Borja MS, Brunborg C, Endresen K, Gullestad L, Birkeland KI, Johansen OE, Oda MN Key Publications

  of 1597 Next page

Go to page: of